z-logo
open-access-imgOpen Access
PATIROMER VS PLACEBO TO ENABLE SPIRONOLACTONE IN PATIENTS WITH RESISTANT HYPERTENSION AND CKD: ANALYSIS ACCORDING TO PATIENT SEX (AMBER TRIAL)
Author(s) -
Bryan Williams,
William Β. White,
Martha Mayo,
Suzette Warren,
Susan Arthur,
Gail Ackourey,
Patrick Rossignol,
Rajiv Agarwal
Publication year - 2021
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000744476.97502.c8
Subject(s) - medicine , spironolactone , placebo , blood pressure , clinical endpoint , urology , randomized controlled trial , endocrinology , heart failure , alternative medicine , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here